The Venture Codex Logo

The Venture Codex

Trevi Health Ventures

660 Madison Avenue, 15th Floor, New York, NY, 10065, United States

Overview

Trevi Health Ventures is a private equity venture capital firm that specializes in growth equity investments. It provides healthcare-focused alternative asset management through private equity funds on a global scale. It also provides development and growth capital for private healthcare companies with emphasis on medical devices, biopharmaceuticals, and healthcare services. The company invests, directly and with its strategic partners, in special situations, traditional buy-outs and structured finance transactions. Trevi Health Ventures is a U.S.-based company that was founded in 2005 by David Robbins and Andrew Fink.

Total investments
2
Lead investments
1
Investments · 12mo
0
Active investors
0

Sector focus

  • Finance
  • Financial Services
  • Venture Capital
Visit website

Investment portfolio

  • US HealthVest

    Participated · Equity · Mar 2013

    US HealthVest operates and develops behavioral health hospitals that deliver inpatient and outpatient psychiatric and substance‑abuse services and specialized programs tailored to community needs. The company partners with existing medical providers to expand services and improve access to care in underserved communities. Its hospitals are accredited by The Joint Commission and serve adolescents, adults and senior adults. US HealthVest currently operates multiple facilities including Chicago Behavioral Hospital, Lake Behavioral Hospital, Silver Oaks Behavioral Hospital, Smokey Point Behavioral Hospital, and two Ridgeview Institute locations, and is developing additional psychiatric hospitals across the country. Founded in 2013 by Dr. Richard Kresch, the company focuses on expanding its facility footprint and service offerings. The recent financing is intended to support both refinancing of existing debt and growth capital for facility expansion. US HealthVest develops and operates behavioral health hospitals and programs, including the Chicago Behavioral Hospital and planned facilities near Atlanta and Seattle. The company provides specialized psychiatric care across inpatient, partial hospitalization, intensive outpatient, medication management, residential treatment and academic programs for children, adolescents, adults and seniors. Its hospitals are accredited by The Joint Commission. US HealthVest was founded in 2013 by Richard A. Kresch, M.D., who serves as President & CEO. The company intends to use the funds from the recent round to further expand its coverage and continue developing new hospitals. US HealthVest focuses on acquiring and developing specialized, high-quality psychiatric facilities and delivering a broad range of inpatient and outpatient programs, including substance abuse treatment. The company plans to expand access to care by developing new facilities and acquiring existing facilities with untapped potential. It emphasizes a patient-centric approach and working closely with local communities to meet unmet needs. US HealthVest is led by Richard Kresch, who previously led Ascend Health, a Polaris-backed operator of nine freestanding behavioral health facilities with nearly 900 beds before its 2012 acquisition. The company announced it has raised $36 million to support its acquisition and development strategy. Investors and management stress combining specialized programs with sound cost structures to improve patient care and scale operations.

  • Manhattan Labs

    Led · Equity · Jan 2013

    Manhattan Labs, founded in 2008, operates as a high-service regional clinical laboratory with facilities in Manhattan and New Jersey, offering concierge-level testing and fast turnaround. The company combines advanced clinical laboratory technology with personalized service and easy-to-access results. Since its founding, Manhattan Labs has experienced approximately 33% annual revenue growth. Leadership includes CEO Ken Cerney, who joined in November 2012, and board member Edgard Zwirn. The company plans to expand into new testing areas, pursue strategic partnerships with physicians, insurers, hospitals and reference labs, and develop new testing panels and value-added services. The added capital is intended to support expansion within Manhattan and into other complementary geographies and to accelerate business development efforts.

Team

No current team members are available.